Contact us for your consultation (706) 250-1960
Anti-diabetic SGLT2 inhibitors may predispose to ketoacidosis Manufactured by Janssen Pharmaceuticals, type II diabetes drug Invokana is a SGLT2 inhibitor that increases urinary excretion of glucose, thereby improving glycemic control and promoting weight loss. Since approval of the first-in-class drug in 2013, the new data suggests that these drugs increase the risk of diabetic ketoacidosis – a… Continue reading
On March 9, 2015, the FDA updated the safety label for Chantix to include how the drug (1) could change the way users react to alcohol and (2) be associated with seizures. Chantix (varenicline) is an FDA-approved prescription drug manufactured by Pfizer, used to help adults quit smoking. Chantix works by reducing cravings for and… Continue reading
The U.S. Food and Drug Administration (FDA) recently announced that it added new information to the label for Tecfidera (dimethyl fumarate) regarding progressive multifocal leukoencephalopathy (PML). The FDA based its decision on a report of a multiple sclerosis (MS) patient who, while being treated with Tecfidera, developed PML then died. The patient was a 54… Continue reading
According to a recent study conducted at the University of Iowa, women who drink a diet soda or two a day have much higher cardiovascular disease rates and are more likely to die from the disease. Diet soda research leads to concern The findings of the study, which was conducted over the course of 10… Continue reading
Following up on an earlier blog post, Harman Law LLC is following a story about a 45-year-old man who took Tecfidera (dimethyl fumarate) for three weeks. He experienced extensive bilateral deep venous thrombosis extending from calf veins to deep femoral veins. Fortunately, the man’s DVT abated after receiving anticoagulation treatment. Tecfidera was approved by the… Continue reading
Covidien Components of Defibrillators May Cause Organ Failure, Strokes or Death The FDA has issued a Class 1 safety alert for the electrodes used in defibrillator medical devices listed below. A Class 1 alert is the most serious issued by the FDA. The concern is that devices using Covidien electrodes may delay or fail to… Continue reading
Asthma Drug Under Scrutiny The Food and Drug Administration issued a Safety Announcement warning that the asthma drug Xolair® increases the risk of heart attack, stroke, chest pain, and blood clots, among other serious problems. Xolair® is an injectable drug that was approved in 2003 to treat moderate to severe asthma in adults and children 12… Continue reading
Jeep Cherokee and Dodge Durango models in recall for defective wiring and potential fire risk After an investigation by the National Highway Traffic Safety Administration (NHTSA), Chrysler has been forced to recall almost 895,000 sport utility vehicles. The recall covers Jeep Grand Cherokee and Dodge Durango models manufactured between 2011 and 2014. The affected models… Continue reading
The FDA issued a drug safety alert that the agency is requiring the manufacturer of the antibiotic Levaquin (levofloxacin) and Avelox (moxifloxacin) to revise the labeling to warn patients of the risk of serious side effects including antibiotic nerve damage. Previously, these drugs were implicated in tendon tears and ruptures in the arms and legs,… Continue reading
Pharmacy Errors Under Scrutiny An article yesterday in the Legal Intelligencer newspaper says that pharmacy errors are on the rise and patient safety is at risk. The sheer increase in the number of people taking prescription drugs alongside the rapid development of pharmacies in every community may in part be a factor, but attorney Brandon… Continue reading
Based on 23 reviews
JarrettMatt has been a warrior during our long and difficult battle for justice.
JasonAfter my grandparents were victims of fraud, Matt fought for their rights.
Denise B.When my child died because of gross negligence, the Harman Law Firm got justice for his memory.
3975 Roswell Road NE
Atlanta, GA, 30342
Phone: (404) 554-0777
info@harmanlaw.com
3540 Wheeler Rd #603
Augusta, GA, 30909
Phone: (706) 250-1960
info@harmanlaw.com
